Publisher: DelveInsight
Category: Diseases & Conditions

Diseases & Conditions market research reports by DelveInsight

(1,146 reports matching your criteria)
    • Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034

      Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, in the 7MM the total market size of wAIHA was ~ USD 300 million. wAIHA is the most common type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric ... Read More

    • Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034

      Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Acute Respiratory Distress Syndrome (ARDS) is a critical condition characterized by the rapid onset of respiratory failure due to extensive inflammation in the lungs. This syndrome can arise from var ... Read More

    • CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032

      CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More

    • Hemophilia B - Pipeline Insight, 2024

      Hemophilia B - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia B - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hemophilia B pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

    • Advanced Renal Cell Carcinoma- Pipeline Insight, 2024

      Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More

    • Diabetes Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

      Diabetes Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Diabetes Drug Market By Drug Type (Insulin, Non-Insulin Drugs, Combination Drugs, And Others), Route Of Administration (Oral, Intravenous, And Subcutaneous), Distribution Channel (Offline And Online) and geogr ... Read More

    • Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024

      Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipel ... Read More

    • Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034

      Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights CAR T-cell therapy has transformed the treatment of aggressive lymphomas such as DLBCL and is now a viable option for RR-FL; however, follow-up remains limited. Identifying appropriate patients for ... Read More

    • Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034

      Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Dry AMD has the potential to progress to geographic atrophy, a stage characterized by irreversible vision loss caused by the depletion of crucial retinal components such as retinal pigment epithelium (R ... Read More

    • Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034

      Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of hemophilia A was the largest in the US among the 7MM, accounting for approximately USD 5,000 million, which is further expected to increase by 2034. In September 2023, concizumab wa ... Read More

    • Hemophilia A - Pipeline Insight, 2024

      Hemophilia A - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia A - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

    • HER2 Negative Breast Cancer- Pipeline Insight, 2024

      HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

    • Psoriatic Arthritis - Pipeline Insight, 2024

      Psoriatic Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Psoriatic Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

    • Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034

      Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Usher Syndrome (USH) is the most common genetic condition responsible for combined loss of hearing and vision. Balance disorders and bilateral vestibular areflexia are also observed in some cases. Limited knowledge ... Read More

    • Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034

      Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, United States accounted for the largest market size in 2023, with approximately USD ~190 million. Aplastic anemia is a rare and severe nonmalignant disease characterized by autoimmune destruction of ... Read More

    • CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032

      CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by ... Read More

    • Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034

      Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of myelofibrosis was highest in the US among the 7MM, accounting for approximately USD 1,400 million, which is further expected to increase by 2034. In the 7MM, JAKAFI/JAKA ... Read More

    • Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology And Market Forecast - 2034

      Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, the United States accounted for the largest market size in 2023, with approximately USD 6,500 million. The disease is reported to occur in 20–50% of those living with diabetes and is t ... Read More

    • Ocular Melanoma - Market Insight, Epidemiology And Market Forecast - 2034

      Ocular Melanoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Stargardt disease, also known as Stargardt’s macular dystrophy or juvenile macular degeneration, is a rare genetic eye disease that happens when fatty material builds up on the macula — the small part of the ret ... Read More

    • Sleep Apnea Implants - Market Insights, Competitive Landscape and Market Forecast-2028

      Sleep Apnea Implants - Market Insights, Competitive Landscape and Market Forecast-2028 Sleep Apnea Implant Market By Product (Hypoglossal Nerve Stimulation Devices, Phrenic Nerve Stimulator Devices, And Others), Indication (Central Sleep Apnea And Obstructive Sleep Apnea), End-User (Hospital & Clini ... Read More

    • Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028

      Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028 Autoimmune Disease Diagnostics Market By Product (Reagents & Kits And Instruments), Disease Type (Localized Autoimmune Disease, And Systemic Autoimmune Disease), Test (Antinuclear Antibody Test, Aut ... Read More

    • Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028

      Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028 Tuberculosis Diagnostics Market By Product Type (Instruments And Assay, Kits, & Reagents), Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, ... Read More

    • Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032

      Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accept ... Read More

    • Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032

      Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights NSCLC market size has seen a revolutionary change in the last decade owing to the increase in incident case of NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibit ... Read More

    • HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032

      HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Recent advancements in HER2 treatments have enhanced HER2-positive breast cancer management, yet relapse remains a primary challenge due to disease heterogeneity and drug resistance mechanisms. In 20 ... Read More

14 15 16 17 18 19 20 21 22 23

Cookie Settings